| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/22/2010 | WO2010012438A3 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 07/22/2010 | WO2010003225A8 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 07/22/2010 | WO2009105328A9 Inorganic sorbent copolymer |
| 07/22/2010 | WO2008155405A9 Crystalline solid forms |
| 07/22/2010 | US20100184853 Terpenes with antifungal activity against malassezia yeasts |
| 07/22/2010 | US20100184850 Phenolic extracts of almond peel containing procyanidins, propelargonidins, and prodelphinidins, and method for preparation thereof |
| 07/22/2010 | US20100184849 Urea oligomers, their preparation process and pharmaceutical compositions containing them |
| 07/22/2010 | US20100184844 Inhibition of Bacterial Protein Production by Polyvalent Oligonucleotide Modified Nanoparticle Conjugates |
| 07/22/2010 | US20100184837 Small-molecule nucleotide aptamer for hepatitis C virus, preparation method and use thereof |
| 07/22/2010 | US20100184834 Immunostimulatory sequence oligonucleotides and methods of using the same |
| 07/22/2010 | US20100184828 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 07/22/2010 | US20100184826 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 07/22/2010 | US20100184825 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 07/22/2010 | US20100184810 Methods and compositions related to riboswitches that control alternative splicing |
| 07/22/2010 | US20100184809 Heterocyclic FXR Binding Compounds |
| 07/22/2010 | US20100184804 Methods for the prevention or treatment of bacterial and fungal infections |
| 07/22/2010 | US20100184800 Compounds for the Treatment of Hepatitis C |
| 07/22/2010 | US20100184789 Inhibitors of protein kinases |
| 07/22/2010 | US20100184780 Inhibitors of protein kinases |
| 07/22/2010 | US20100184767 Substituted oxazolidinones and use thereof |
| 07/22/2010 | US20100184762 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
| 07/22/2010 | US20100184751 Heterocyclic compounds for the treatment of tuberculosis |
| 07/22/2010 | US20100184747 Indoline derivatives and their use in treating disease-states such as cancer |
| 07/22/2010 | US20100184746 potent antimicrobial activity against macrolide resistant streptococcus pneumococci against which lincomycin and clindamycin are ineffective; therapeutic agents for infectious diseases in respiratory organs |
| 07/22/2010 | US20100184727 Treatment of excess sebum production |
| 07/22/2010 | US20100184723 Carbohydrate-lipid constructs and their use in preventing or treating viral infection |
| 07/22/2010 | US20100184718 Compositions and Methods for Double-Targeting Virus Infections and Targeting Cancer Cells |
| 07/22/2010 | US20100184716 Pharmaceutical compositions with superior product performance and patient compliance |
| 07/22/2010 | US20100184711 Alpha-GLYCOSYL THIOLS AND alpha-S-LINKED GLYCOLIPIDS |
| 07/22/2010 | US20100184708 Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| 07/22/2010 | US20100184704 Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agent |
| 07/22/2010 | US20100184701 Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof |
| 07/22/2010 | US20100184698 Use of a deslorelin and mastoparan as a therapeutic agent |
| 07/22/2010 | US20100184696 Peptides and Their Use |
| 07/22/2010 | US20100184693 Methods and systems for generating and evaluating peptides |
| 07/22/2010 | US20100184684 Antibacterial and antifungal peptides |
| 07/22/2010 | US20100184683 Antibacterial and antifungal peptides |
| 07/22/2010 | US20100184682 Composition and Methods for the Inhibition of Membrane Fusion by Paramyxoviruses |
| 07/22/2010 | US20100184681 Antibacterial and antifungal peptides |
| 07/22/2010 | US20100184680 Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43 |
| 07/22/2010 | US20100184679 Use of a combination of cart peptides as a therapeutic agent |
| 07/22/2010 | US20100184678 Use of a peptide as a therapeutic agent |
| 07/22/2010 | US20100184677 Use of the human pancreatic polypeptide as a therapeutic agent |
| 07/22/2010 | US20100184675 Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agent |
| 07/22/2010 | US20100184674 Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agent |
| 07/22/2010 | US20100184673 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent |
| 07/22/2010 | US20100184663 Methods and Compositions Related to Inhibition of Viral Entry |
| 07/22/2010 | US20100184654 Anti-microbial targeting chimeric pharmaceutical |
| 07/22/2010 | US20100184647 Use of Epinecidin-1 Peptides and Anti-lipopolysaccharide Factor Peptides for Treating Microbial Infection |
| 07/22/2010 | US20100184607 Monosaccharide compounds and methods therefor |
| 07/22/2010 | US20100184207 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules |
| 07/22/2010 | US20100184019 Novel Human Virus Causing Severe Acute Respiratory Syndrome (SARS) and Uses Thereof |
| 07/22/2010 | US20100183716 Tableted compositions containing atazanavir |
| 07/22/2010 | US20100183715 Tableted compositions containing atazanavir |
| 07/22/2010 | US20100183713 Gastrointestinal-specific multiple drug release system |
| 07/22/2010 | US20100183707 Methods and compositions for treating hiv infection |
| 07/22/2010 | US20100183704 dsRNA FOR TREATING VIRAL INFECTION |
| 07/22/2010 | US20100183692 compositions |
| 07/22/2010 | US20100183691 Use of Titanium metal fine-particles for increasing the effect of Germicidal medicines used for human skin dermatosis, skin infection and traumatism |
| 07/22/2010 | US20100183677 Fusion proteins of mycobacterium tuberculosis |
| 07/22/2010 | US20100183676 Compositions comprising opa protein epitopes |
| 07/22/2010 | US20100183674 immunization; comprised of a fusion protein; bioterrorism; plague |
| 07/22/2010 | US20100183672 Process for preparing live smallpox vaccine |
| 07/22/2010 | US20100183670 Method for identifying motifs and/or combinations of motifs having a boolean state of predetermined mutation in a set of sequences and its application |
| 07/22/2010 | US20100183666 Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences |
| 07/22/2010 | US20100183665 Promoterless cassettes for expression of alpha virus structural proteins |
| 07/22/2010 | US20100183664 Attenuated recombinant newcastle disease virus and vaccine containing the same |
| 07/22/2010 | US20100183663 Intergenic regions as novel sites for insertion of hiv dna sequences in the genome of modified vaccinia virus ankara |
| 07/22/2010 | US20100183656 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| 07/22/2010 | US20100183654 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis |
| 07/22/2010 | US20100183650 Antigen Delivery Vectors and Constructs |
| 07/22/2010 | US20100183649 Method of producing virus-like particles of picornavirus using a small-ubiquitin-related fusion protein expression system |
| 07/22/2010 | US20100183647 Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 07/22/2010 | US20100183642 Novel multimeric cd40 ligands, method for preparing same and use thereof for preparing drugs |
| 07/22/2010 | US20100183638 Restrictive agonist of toll-like receptor 3 (tlr3) |
| 07/22/2010 | US20100183636 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 07/22/2010 | US20100183635 Glycosylated specificity exchangers |
| 07/22/2010 | US20100183628 Random homozygous gene perturbation (rhgp) with thermal assymetric interlaced (tail)-pcr |
| 07/22/2010 | US20100183623 Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein |
| 07/22/2010 | US20100183622 Vpr function and activity |
| 07/22/2010 | US20100183614 Immunoglobulins directed to bacterial, viral and endogeneous polypeptides |
| 07/22/2010 | US20100183613 Methods of using mevalonate decarboxylase (mvd) antagonists |
| 07/22/2010 | US20100183591 Modulation of nkg2d |
| 07/22/2010 | US20100183567 Novel Mammalian Multipotent Stem Cells and Compositions, Methods of Preparation and Methods of Administration Thereof |
| 07/22/2010 | US20100183557 Ptra gene and uses thereof |
| 07/22/2010 | US20100183555 Methods and kits for determining drug sensitivity in patients infected with hcv |
| 07/22/2010 | US20100183552 1-[2-amino-3-(substituted alkyl)-3h-benzimidazolylmethyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs |
| 07/22/2010 | US20100183551 Macrocyclic Compounds As Antiviral Agents |
| 07/22/2010 | US20100183519 Topical Poloxamer Formulations for Enhancing Microvascular Flow: Compositions and Uses Thereof |
| 07/22/2010 | US20100183518 Vaccine Against Group A Beta Hemolytic Streptococcus And Respective Process For Obtaining Thereof |
| 07/22/2010 | CA2751892A1 Benzo [c] phenanthridines as antimicrobial agents |
| 07/22/2010 | CA2749572A1 Combination antibodies for the treatment and prevention of disease caused by bacillus anthracis and related bacteria and their toxins |
| 07/22/2010 | CA2746964A1 Pulmonary administration of immunoglobulin single variable domains and constructs thereof |
| 07/22/2010 | CA2673636A1 Dental composition and method |
| 07/21/2010 | EP2208793A1 Protein providing inducible resistance to glycopeptides, in particular in gram-positive bacteria |
| 07/21/2010 | EP2208736A2 Endogenous retrovirus up-regulated in prostate cancer |
| 07/21/2010 | EP2208732A1 Deshydroxy vancomycin, the preparation, pharmaceutical composition and the use |
| 07/21/2010 | EP2208730A1 Polymorphic forms of rifaximin, processes for their production and use thereof in medicinal preparations |
| 07/21/2010 | EP2208729A1 Oxazolidinone derivative having 7-membered hetero ring |
| 07/21/2010 | EP2207819A1 Anti-microbial polymers and their compositions |